Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;10(3):e331.
doi: 10.1016/S2214-109X(21)00592-1.

Fluvoxamine for the treatment of COVID-19

Catia Marzolini  1 , Fiona Marra  2 , Alison Boyle  2 , Saye Khoo  3 , David J Back  3
Affiliations
Comment

Fluvoxamine for the treatment of COVID-19

Catia Marzolini et al. Lancet Glob Health. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CM received a research grant from Gilead; and lecture honoraria from Merck Sharpe and Dohme and ViiV Healthcare. FM has received an educational grant from Gilead Sciences and Abbvie; consultancy fees from Gilead Sciences, ViiV Healthcare, and Merck; and lecture fees from Gilead and ViiV. AB has received educational grants and lecture honoraria from Gilead and Abbvie. SK has received educational grants for the Liverpool drug interaction website (www.covid-druginteractions.org), AbbVie, Gilead Sciences, Merck Sharpe and Dohme, Novartis, and Sobi; speakers’ honoraria from ViiV Healthcare, Gilead Sciences, and AbbVie; consultancy fees from ViiV Healthcare and Merck; and research funding from Gilead Sciences, and ViiV Healthcare. DJB has received educational grants from AbbVie, Novartis, Merck, Gilead, and Sobi; DJB has received lecture fees from AbbVie, Gilead Sciences, Merck, ViiV Healthcare; and consultancy fees from Gilead Sciences.

Comment on

References

    1. Reis G, Dos Santos Moreira-Silva EA, Silva DCM, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022;10:e42–e51. - PMC - PubMed
    1. University of Liverpool COVID-19 Drug interaction. https://www.covid19-druginteractions.org
    1. Van Harten J. Overview of the pharmacokinetics of fluvoxamine. Clin Pharmacokinet. 1995;29(suppl 1):1–9. - PubMed
    1. Jazz Pharmaceuticals Fluvoxamine (Luvox highlights of prescribing information 2008) Nov 23, 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022235lbl.pdf